Your cart

Your cart is empty

Start learning
Congratulations!
Module Completed
Continue Learning
Not ready yet → Continue Learning
Ready to apply this in practice?

Prescribe with confidence

Book a free session for step-by-step prescribing and TGA pathway guidance.

Book support session
Not ready yet → Continue Learning

THIS CONTENT IS EXCLUSIVE TO SAGED MEMBERS.🔒

Please log in to your member account or sign up to view these contents in full.

Safety & Contraindications
Safety & Contraindications

Safety & Contraindications

0 LEARNING CREDITS
LOG IN OR SIGN UP

    • Overview

      The lack of formal education on medicinal cannabis makes it difficult for patients and medical practitioners to discuss medical cannabis as part of a treatment plan, despite a growing demand from patients for alternative medications.1 

      A report found that general practitioners (GPs) felt uncomfortable discussing medicinal cannabis with patients due to their limited knowledge, concerns about safety, and confusion around the appropriateness of medical cannabis for certain patients.2

      This course aims to address this knowledge gap by providing doctors with information on absolute and relative contraindications, adverse events associated with medicinal cannabis, and the social impact around medicinal cannabis on driving and safety-sensitive tasks.

      Estimated Duration: 1.5 hours

      Access Duration: 12 months from date of purchase

      Learning Outcomes

      1. Identify patient factors, contraindications and comorbidities relevant to assessing the suitability of medical cannabis for an individual
      2. Interpret clinical information to determine when medical cannabis may be prescribed safely and appropriately
      3. Assess and manage potential drug–drug interactions, adverse effects and cannabis-related disorders
      4. Apply legal and safety requirements, including driving laws, state-based prescribing regulations, workplace considerations, and safe storage guidance
      5. Select appropriate administration pathways based on patient needs, comorbidities, lifestyle, and risk profile
      6. Develop, document, and communicate informed consent, including risks, benefits, treatment goals, alternatives, and discontinuation plans
      7. Implement strategies for monitoring, follow-up, and reporting adverse events in alignment with best practice and TGA guidance

    Overview

    The lack of formal education on medicinal cannabis makes it difficult for patients and medical practitioners to discuss medical cannabis as part of a treatment plan, despite a growing demand from patients for alternative medications.1 

    A report found that general practitioners (GPs) felt uncomfortable discussing medicinal cannabis with patients due to their limited knowledge, concerns about safety, and confusion around the appropriateness of medical cannabis for certain patients.2

    This course aims to address this knowledge gap by providing doctors with information on absolute and relative contraindications, adverse events associated with medicinal cannabis, and the social impact around medicinal cannabis on driving and safety-sensitive tasks.

    Estimated Duration: 1.5 hours

    Access Duration: 12 months from date of purchase

    Learning Outcomes

    1. Identify patient factors, contraindications and comorbidities relevant to assessing the suitability of medical cannabis for an individual
    2. Interpret clinical information to determine when medical cannabis may be prescribed safely and appropriately
    3. Assess and manage potential drug–drug interactions, adverse effects and cannabis-related disorders
    4. Apply legal and safety requirements, including driving laws, state-based prescribing regulations, workplace considerations, and safe storage guidance
    5. Select appropriate administration pathways based on patient needs, comorbidities, lifestyle, and risk profile
    6. Develop, document, and communicate informed consent, including risks, benefits, treatment goals, alternatives, and discontinuation plans
    7. Implement strategies for monitoring, follow-up, and reporting adverse events in alignment with best practice and TGA guidance

    Recently viewed

    This is member-only content.

    Sign up for free or log in to view.

    SIGN UP OR LOG IN